Article de Périodique
A public health approach to increased synthetic cannabinoid-related morbidity among New York City residents, 2014-2015 [Viewpoint] (2016)
Auteur(s) :
NOLAN, M. L. ;
ALLEN, B. ;
KUNINS, H. V. ;
PAONE, D.
Année
2016
Page(s) :
101-103
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs
Discipline :
SAN (Santé publique / Public health)
Thésaurus géographique
ETATS-UNIS
Thésaurus mots-clés
CANNABINOIDES
;
DROGUES DE SYNTHESE
;
MORBIDITE
;
URGENCE
;
TOXICOLOGIE
;
URINE
;
SANTE PUBLIQUE
Résumé :
Despite continued prohibition of most drugs for recreational use, drug use is common in the United States. In 2013, nearly half of adults aged 12 years and older reported lifetime use of illicit drugs (47%), with 44% reporting lifetime cannabis use (SAMHSA, 2014a). However, US federal law prohibits the manufacture, possession, sale, or consumption of cannabis. In addition, products containing a variety of synthetic cannabinoids (SCs), many of which are not controlled, have emerged in recent years. SCs include chemical compounds that bind to cannabinoid receptors in the brain (Brents and Prather, 2014 and Gurney et al., 2014). [Extract]
Affiliation :
New York City Department of Health and Mental Hygiene, Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, Queens, NY, USA
Cote :
Abonnement
Historique